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We used whole-genome sequencing to investigate the evo-
lutionary context of an emerging highly pathogenic strain 
of Shiga toxin–producing Escherichia coli (STEC) O157:H7 
in England and Wales. A timed phylogeny of sublineage 
IIb revealed that the emerging clone evolved from a STEC 
O157:H7 stx-negative ancestor ≈10 years ago after acquisi-
tion of a bacteriophage encoding Shiga toxin (stx) 2a, which 
in turn had evolved from a stx2c progenitor ≈20 years ago. 
Infection with the stx2a clone was a significant risk factor 
for bloody diarrhea (OR 4.61, 95% CI 2.24–9.48; p<0.001), 
compared with infection with other strains within sublineage 
IIb. Clinical symptoms of cases infected with sublineage IIb 
stx2c and stx-negative clones were comparable, despite the 
loss of stx2c. Our analysis highlighted the highly dynamic 
nature of STEC O157:H7 Stx-encoding bacteriophages and 
revealed the evolutionary history of a highly pathogenic 
clone emerging within sublineage IIb, a sublineage not pre-
viously associated with severe clinical symptoms.
Shiga toxin–producing Escherichia coli (STEC) O157:H7 cause a wide range of gastrointestinal symp-
toms, including mild gastroenteritis, abdominal pain, vom-
iting, and bloody diarrhea (1). A subset of patients, most 
commonly the very old and the very young, go on to devel-
op hemolytic uremic syndrome (HUS) (2). STEC O157:H7 
are zoonotic, and transmission to humans is most common-
ly associated with ruminants, especially cattle and sheep. 
Transmission occurs by consumption of contaminated food 
or water or by direct contact with animals or their environ-
ment. The infectious dose is low (10–100 organisms), and 
person-to-person spread can occur in households, nurseries, 
and other institutional settings (1). The STEC pathotype is 
defined by the presence of the genes encoding Shiga toxin 
(Stx) type 1, type 2, or both, located on a bacteriophage 
incorporated into the bacterial genome (3). Stx1 and Stx2 
can be further divided into subtypes Stx1a–1d and Stx2a–
2g; Stx2a is strongly associated with causing severe disease 
(4,5). The STEC O157:H7 population has previously been 
delineated into 3 main lineages (I, I/II, and II) (6), and 7 
sublineages (Ia, Ib, Ic, IIa, IIb, IIc, and I/ll) (5).
In England, the most common STEC serotype is 
O157:H7, which causes an average of 800 cases/year (1). 
All STEC O157:H7 isolated at local hospital laborato-
ries from fecal samples from hospitalized patients and all 
cases in the community are submitted to the Gastrointes-
tinal Bacteria Reference Unit (GBRU) at Public Health 
England for confirmation of identification and typing. 
From 2000 through 2016, phage type (PT) 8 with the stx 
profile stx1a/stx2c and PT21/28 with the stx profile stx2a 
or stx2a/stx2c were detected most frequently in England, 
with PT21/28 the most frequently associated with severe 
disease (2,7).
Since 2015, all isolates submitted to GBRU have 
been genome sequenced. Whole-genome sequencing 
(WGS) demonstrates unparalleled sensitivity and accu-
racy in identifying linked cases (8). Using WGS data dur-
ing outbreak investigations has improved the robustness 
of case ascertainment and provided forensic evidence 
for linking human cases to the source of their infection 
(9,10). Phylogenetic inference can also reveal how strains 
are related over time and space more accurately than other 
molecular typing methods and may provide insight into 
the evolutionary and epidemiologic context of emerging 
pathogenic clones (8,10,11).
In 2015, a total of 47 persons were affected by an 
outbreak in England of foodborne gastrointestinal illness 
caused by STEC O157:H7 PT8 stx2a. The outbreak was as-
sociated with the consumption of contaminated prepacked 
salad leaves (11). The outbreak strain continued to cause 
sporadic infection and outbreaks of foodborne disease 
throughout 2016 and 2017 (11). The aim of our analysis 
was to investigate the evolutionary history of this newly 
emergent strain of STEC O157:H7 PT8 stx2a and assess 
the risk to public health.
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Materials and Methods
Bacterial Strains
All isolates submitted to GBRU for confirmation and typ-
ing from local hospital laboratories in England and Wales 
during July 2015–December 2017 were sequenced for rou-
tine surveillance (National Center for Biotechnology In-
formation Short Read Archive bioproject PRJNA248042). 
We included an additional 74 clinical isolates of STEC 
O157:H7 belonging to sublineage IIb, the lineage con-
taining STEC O157:H7 PT8 stx2a, that were submitted to 
GBRU between January 2010–June 2015 from previous 
studies (5,8) (online Technical Appendix Table, https://
wwwnc.cdc.gov/EID/article/24/12/18-0409-Techapp1.
pdf). We selected these STEC O157:H7 isolates on the 
basis of stx subtype and phage type diversity to provide 
context as a sample of the background population. We 
defined STEC O157:H7 isolates from patients who were 
hospitalized as a result of their gastrointestinal symptoms 
or who reported bloody diarrhea as highly pathogenic or 
as having increased pathogenic potential compared with 
isolates from patients who were asymptomatic or reporting 
nonbloody diarrhea.
Genome Sequence Analysis
For WGS, we extracted DNA from cultures of STEC 
O157:H7 for sequencing on the HiSeq 2500 instrument (Il-
lumina, San Diego, California, USA). We mapped qual-
ity trimmed Illumina reads (12) to the STEC O157:H7 
reference genome Sakai (GenBank accession no. BA000007) 
using Burrows Wheeler Aligner-Maximum Exact Matching 
(BWA-MEM) (13). We identified single- nucleotide poly-
morphisms (SNPs) using Genome Analysis Toolkit version 
2 (14) in unified genotyper mode and extracted core genome 
positions that had a high-quality SNP (>90% consensus, mini-
mum depth ×10, GQ >30) in >1 isolate for further analysis. 
We performed hierarchical single linkage clustering on the 
pairwise SNP difference between all strains at various dis-
tance thresholds (250, 100, 50, 25, 10, 5, 0). The result of the 
clustering is a SNP profile, or SNP address, that can be used 
to describe population structure based on clonal groups (15). 
We performed recombination analysis using Gub-
bins (16) and reconstructed timed phylogenies using 
BEAST-MCMC version 2.4.7 (17). We computed alter-
native clock models and population priors and assessed 
their suitability on the basis of Bayes factor tests. The 
highest supported model was a relaxed log-normal clock 
rate with a Bayesian skyline population model. We ran 
all models with a chain length of 1 billion. We recon-
structed a maximum clade credibility tree using TreeAn-
notator version 1.75 (17).
We performed Stx subtyping as described by Ashton 
et al. (18). The integration of Stx-encoding prophage into 
the host genome has been characterized into 6 target genes: 
wrbA, encoding a NAD quinone oxidoreductase; yehV, a 
transcriptional regulator; sbcB, an exonuclease; yecE, a gene 
of unknown function; the tRNA gene argW; and Z2577, 
which encodes an oxidoreductase (5). We mapped short 
Figure 1. Cases of Shiga toxin–producing Escherichia coli O157:H7 belonging to sublineage IIb, 250 single-nucleotide polymorphism 
single-linkage cluster 18.%, by stx subtype profile, submitted to the Gastrointestinal Bacterial Reference Unit at Public Health England 
from England and Wales during June 1, 2010–December 31, 2017. 
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reads from the STEC O157:H7 genomes to intact refer-
ence sequences of these genes, and aligned them with BWA 
MEM (13). We defined occupied Stx bacteriophage inser-
tion (SBI) sites as those strains that had disrupted alignments 
(5). We used Tablet to visualize read pileups (19).
Data Analyses
The National Enhanced Surveillance System for STEC 
(NESSS) in England was implemented on January 1, 2009, 
and has been described in detail elsewhere (1). For this study, 
we extracted data from NESSS for the cases identified as be-
ing infected with strains that had been sequenced and belong-
ing to the sublineage IIb cluster of interest (containing the 
STEC O157:H7 PT8 stx2a, outbreak strain). We excluded 
asymptomatic carriers detected through screening high-risk 
contacts of symptomatic patients as well as patients who did 
not return the enhanced surveillance questionnaire (ESQ) to 
NESSS. Data analyzed included age, gender, and whether 
the patient reported symptoms of nonbloody diarrhea, bloody 
diarrhea, and vomiting along with whether cases were hos-
pitalized, developed typical HUS, or died. Cases were cat-
egorized into children (<16 years of age) or adults, based 
on a priori knowledge that children are most at risk for both 
STEC infection and progression to HUS (1). Where clinical 
symptoms were blank on the ESQ, we coded them as nega-
tive responses for these symptoms. We divided cases into 3 
groups based on stx subtype: stx2a, stx2c, and stx-negative.
We first described patients’ symptoms by stx subtype 
as well as by age group and sex and also examined the dis-
tribution of stx subtype by age and gender. We used Fisher 
exact tests to compare proportions among different groups. 
We assessed reporting of bloody diarrhea or hospitalization 
as a marker of disease severity by stx subtype. We used 
logistic regression to calculate odds ratios (ORs) to assess 
bloody diarrhea by stx subtype while adjusting for age 
(child/adult) and sex. We performed all analyses in Stata 
13.0 (StataCorp LLC, College Station, TX, US).
Results
Sublineage IIb
The STEC O157:H7 stx2a clone analyzed in this study was 
located within sublineage IIb, and belonged to a 250 SNP 
single-linkage cluster, designated 18%. This cluster com-
prised 251 clinical isolates: 138 of STEC O157:H7 stx2a, 77 
of stx-negative E. coli O157:H7, and 36 of STEC O157:H7 
stx2c (Figure 1; online Technical Appendix Table). Since 
July 2015, when Public Health England implemented the 
use of WGS for STEC, the number of cases identified with-
in sublineage IIb has remained stable (≈60/y). However, 
the number of cases of the stx-negative E. coli O157:H7 
clone has declined, whereas the stx2a and stx2c clones are 
increasing (Figure 1).
Evolutionary Timescale and Stx Prophage Insertion in 
STEC O157:H7
We reconstructed a timed phylogeny of sublineage IIb 
(Figure 2). We calculated the mutation rate of STEC 
O157:H7 within sublineage IIb to be ≈2 mutations per 
genome per year (95% highest posterior density [HPD] 
1.7–2.4). This rate is less than the 2.6 mutations per ge-
nome per year previously calculated across the complete 
STEC O157 population (5). Our analysis revealed that the 
emerging stx2a clone evolved from a stx-negative recent 
ancestor with the acquisition of stx2a ≈10 years ago (95% 
HPD 9.0 years 12.7 years). Previously, this stx-negative 
clone had evolved from a stx2c progenitor ≈20 years ago 
(95% HPD 17.6 years–24.6 years) after the loss of stx2c.
Figure 2. Timed phylogeny of Shiga toxin–producing 
Escherichia coli O157:H7 sublineage IIb isolates illustrating 
the sequential loss of stx2c and subsequent gain of stx2a. Red 
indicates stx2a; green, stx negative; blue, stx2c. Scale bar 
indicates years in the past.
Historically, the majority of strains in sublineage IIb har-
bored a Stx2c-encoding prophage at sbcB, with the yehV SBI 
site occupied by a truncated non–Stx-encoding prophage (5). 
Analysis of the short read data indicated that in the stx-nega-
tive sublineage IIb clone, yehV was disrupted but sbcB was in-
tact, indicating the loss of the Stx2c-encoding prophage from 
the SBI site. The more recently emerged sublineage IIb stx2a 
clone had disrupted SBI sites at sbcB and yehV only, indicat-
ing that a Stx2a-encoding phage had been inserted into sbcB, 
the site left vacant in the stx-negative clone after the loss 
of stx2c.
Disease Severity of Clinical Cases within  
the Sublineage IIb Cluster by stx Subtype
Overall, 91.6% patients (230/251, 95% CI 88.1–95.1) had 
symptoms of diarrhea, and similar percentages were re-
ported regardless of the stx subtype profile of the STEC 
O157:H7 causing the infection (Table 1). Rates of other 
symptoms varied; 28.3% of patients (71/251, 95% CI 22.7–
33.9) reported vomiting, 35.1% (88/251, 95% CI: 29.1–41.0) 
experienced bloody diarrhea, and 18.7% (47/251, 95% CI: 
13.9–23.5) were hospitalized. Hospitalization occurred more 
often for patients reporting bloody diarrhea (35.2% [31/88, 
95% CI 25.0–45.4]) than those without bloody diarrhea 
(9.8% [16/163], 95% CI 5.2–14.1; p<0.001). Half (50.0%) 
of patients infected with stx2a isolates reported bloody di-
arrhea (69/138, 95% CI 41.5–58.4), compared with 15.6% 
of patients infected with stx-negative isolates (12/77, 95% 
CI 7.3–23.9) and 19.4% of those infected with stx2c isolates 
(7/36, 95% CI 5.9–33.0; p<0.001). No patients were known 
to experience HUS, and none died.
Among the 251 clinical cases, 141 (56.2%, 95% CI 
50.0%–62.3%) were adults and 136 (54.2%, 95% CI 
48.0%–60.4%) were female. Adult patients were infected 
with stx2a strains (61.0% [86/141], 95% CI 52.8%–69.1%) 
more often than children (47.3% [52/110], 95% CI 37.8%–
56.7%; p = 0.030). Conversely, children were more often in-
fected with stx-negative strains than adults: 41.8% (46/110) 
of children (95% CI 32.4%–51.2%) versus 22.0% (31/141) 
of adults (95% CI 15.1%–28.9%; p = 0.001). There was 
also variation in stx subtype by sex; proportionately more 
female patients were infected with stx2a strains (61.0% 
[83/136], 95% CI 52.7%–69.3%) than were male patients 
(47.8% [55/115], 95% CI 38.6%–57.1%; p = 0.036). Adult 
patients reported bloody diarrhea (46.8% [66/141], 95% CI 
38.5%–55.1%) more often than children (20.0% [22/110], 
95% CI 12.2%–27.6%; p<0.001), as did female patients 
(40.4% [55/136], 95% CI 32.1%–48.8%) compared with 
 
Table 1. Clinical features of cases of Shiga toxin–producing Escherichia coli O157:H7 belonging to the IIb 250 SNP single-linkage 
cluster 18.% by stx subtype clone, England and Wales, July 2015–December 2017* 
stx subtype 
No. 
patients 
Diarrhea 
 
Bloody diarrhea† 
 
Vomiting 
 
Hospitalization‡ 
No. 
patients  
% Patients 
(95% CI) 
No. 
patients  
% Patients 
(95% CI) 
No. 
patients  
% Patients 
(95% CI) 
No. 
patients  
% Patients 
(95% CI) 
stx2c 36 31 86.1  
(74.2–98.0) 
 7 22.6 
(5.9–33.0) 
 10 32.3 
(12.4–43.1) 
 3 8.3 
1.1 to 17.8) 
stx-negative 77 72 93.5 
(87.8–99.1) 
 12 16.7 
(7.3–23.9) 
 23 31.9 
(19.4–40.3) 
 9 11.7 
(4.3–19.0) 
stx2a 138 127 92.0 
(87.4–96.6) 
 69 54.3 
(41.5–58.4) 
 38 29.9 
(20.0–35.1) 
 35 25.4 
(18.0–32.7) 
Total 251 230 91.6 
(88.1–95.1) 
 88 38.3 
(29.1–41.0) 
 71 30.9 
(22.7–33.9) 
 47 18.7 
(13.9–23.5) 
*SNP, single-nucleotide polymorphism. 
†Statistically significant difference in reporting by stx subtype using Fisher exact test (p<0.001) 
‡Statistically significant difference in reporting by stx subtype using Fisher exact test (p = 0.011) 
 
 
Table 2. Univariable and multivariable logistic regression analysis for reported bloody diarrhea in cases of Shiga toxin–producing 
Escherichia coli O157:H7 belonging to the IIb, 250 SNP single-linkage cluster 18.% by stx subtype clone, England and Wales, July 
2015–December 2017*   
Exposure 
No. (%) 
patients with 
bloody diarrhea 
No. (%) 
patients without 
bloody diarrhea  
   
Univariable analysis 
 
Multivariable analysis† 
OR (95% CI) p value OR (95% CI) p value 
stx subtype      
 stx negative 12 (16.7) 65 (83.3) Reference  Reference 
 stx2c 7 (22.6) 29 (77.4) 1.31 (0.47–3.7) 0.61  1.01 (0.35–2.94) 0.978 
 stx2a 69 (54.3) 69 (45.7) 5.42 (2.69–10.91) <0.001  4.61 (2.24–9.48) <0.001 
Age        
 Child, <16 y 22 (20.0) 88 (80.0) 0.28 (0.16–0.50) <0.001  0.31 (0.17–0.58) <0.001 
 Adult, >16 y 66 (46.8) 75 (53.2) Reference  Reference 
Sex      
 F 55 (40.4) 81 (59.6) Reference  Reference 
 M 33 (28.7) 82 (71.3) 0.59 (0.35–1.01) 0.053  0.81 (0.45–1.47) 0.494 
*OR, odds ratio; SNP, single-nucleotide polymorphism.  
†Adjusted for each exposure variable (stx subtype, sex, age). 
 
RESEARCH
2306 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 24, No. 12, December 2018
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 24, No. 12, December 2018 2307
Highly Pathogenic Clone of STEC O157
male patients (28.7% [33/115], 95% CI 20.3%–37.1%), al-
though the difference was not statistically significant (p = 
0.05). The proportion of patients hospitalized did not differ 
significantly by sex or age group (data not shown).
After adjusting for age (adult or child) and sex, the 
odds ratio of experiencing bloody diarrhea was significant-
ly higher in those infected with the stx2a clone compared 
with patients infected with the stx-negative clone (Table 2). 
The odds of bloody diarrhea were no different for cases in-
fected with the stx2c clone than for the stx-negative clone. 
Among the cases analyzed, being a child was protective for 
symptoms of bloody diarrhea.
Discussion
The data described here support previous studies that 
showed the acquisition and loss of the Stx-encoding phage 
is highly dynamic in STEC O157:H7 (5,20). Most com-
monly described is the acquisition of stx1a or stx2a by a 
STEC O157:H7 stx2c progenitor, followed by the subse-
quent loss of stx2c in strains that acquired stx2a. The in-
volvement of a stx-negative intermediate in this process, as 
captured here, has not been previously described. The loss 
of the Stx2c-encoding phage appears to have facilitated the 
acquisition of the Stx2a-encoding phage because the latter 
was inserted into the same SBI site, sbcB, left vacant by the 
Stx2c-encoding phage.
Using phylogenetic analysis of variation at the whole-
genome level, we reconstructed the recent evolutionary 
history of this emerging pathogenic clone within STEC 
O157:H7 sublineage IIb. We observed the loss of stx2c 
from the stx2c progenitor that caused a stx-negative clone 
≈20 years ago, followed by the acquisition of stx2a ≈10 
years ago, and later expansion as shown in Figure 1. Previ-
ously, we showed that the historic acquisition of a Stx2a-
encoding bacteriophage by a population of STEC O157:H7 
PT2 stx2c, belonging to lineage I/II indigenous in the UK 
cattle population, was associated with the first outbreaks of 
childhood HUS in England in the early 1980s (5,7). Sub-
sequently, the increase in the incidence of STEC O157:H7 
PT21/28 during the 1990s was linked to the acquisition of 
stx2a by an indigenous population of STEC O157:H7 stx2c 
belonging to sublineage Ic, resulting in the highly pathogen-
ic contemporary clone STEC PT21/28 stx2a/stx2c (1,2,5,7). 
This clone has been associated with several outbreaks in 
the United Kingdom associated with a high incidence of 
HUS (10,21–23). Here, we described an E.coli O157:H7 
clone from yet another UK domestic lineage (sublineage 
IIb) that has recently acquired the Stx2a-encoding phage 
and is showing evidence of increasing pathogenic potential.
The analysis of disease severity of clinical cases by 
stx subtype of isolates of STEC O157:H7 within the same 
sublineage IIb cluster showed a significant association 
between the presence of stx2a and markers of disease 
severity; specifically, bloody diarrhea linked to higher rates 
of hospitalization. Previous studies have reported evidence 
of increased pathogenicity of STEC harboring stx2a (4,5). 
However, these studies report on STEC from a wide range 
of different serotypes, exhibiting a wide variety of stx sub-
types and are based on relatively small datasets. In this 
study, we present the analysis of a large dataset focusing 
on a specific clade within a single serotype characterized by 
a limited number of stx subtype combinations, specifically 
stx2c, stx negative, and stx2a only. This analysis enabled 
us to make direct comparisons between specific stx profiles 
while limiting the influence of other factors in the genome.
Strains of Stx-negative E. coli O157:H7 are regarded 
as atypical enteropathogenic E. coli (EPEC), defined by the 
presence of the intimin gene (eae) and the absence of stx 
and the E. coli adherence factor (EAF) plasmid (24). EPEC 
are a common cause of infantile diarrhea and travelers’ di-
arrhea and are known to cause mild diarrhea in adults (25). 
In this study, the fact that clinical cases infected with the 
E. coli O157:H7 stx-negative clone reported a similar fre-
quency of symptoms, including bloody diarrhea and hospi-
talization, as those infected with STEC O157:H7 stx2c de-
spite the loss of stx was an unexpected finding that requires 
further investigation.
A timed phylogenetic reconstruction of the evolution-
ary history of a cluster of sublineage IIb charted the recent 
emergence of a highly pathogenic clone of STEC O157:H7 
stx2a. The symptom of bloody diarrhea, a marker of sever-
ity and predictor of HUS development (2), was strongly 
associated with cases infected with isolates of STEC 
O157:H7 harboring stx2a compared with those isolates 
without stx or those with stx2c. Our analysis also illustrated 
the highly dynamic nature of the Stx-encoding phages. In 
contrast to the observed excision events of stx2c-encoding 
phages in O157:H7, there is evidence to suggest that once 
a Stx2a-encoding phage is integrated into a population it 
tends to be maintained (5). As such, the emergence of yet 
another sublineage of STEC O157:H7 acquiring stx2a is of 
public health concern. Through this study, we demonstrate 
that STEC O157:H7 WGS surveillance data have a role 
in monitoring and anticipating emerging threats to public 
health and in contributing to our understanding of the un-
derlying pathogenic mechanisms associated with severe 
gastrointestinal illness.
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